Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

Acquired byC. R. Bard
Price$200M
Date8/2013

General Information

Offices

Minneapolis, USA
2700 Freeway Boulevard,
Suite 800
Minneapolis, MN, 55430
USA

People

Chief Financial Officer

Funding

TOTAL $115k
FUNDING TOTAL $115k
Convertible Note, 9/2009
$100k
Seed, 9/2012
$15k

Tags

Medafor

Medafor, Inc. is a medical device company that has developed and commercialized a patented hemostatic agent that has been shown to enhance and accelerate the normal blood clotting process. Medafor’s MPH technology is unparalleled in terms of safety, efficacy, and cost.

Recent Milestones

Videos

Screenshots

Medafor screenshot
Above: Home Page
Uploaded: 7/19/13

Sources

  1. Biotech firm Medafor sold to C. R. Bard for $200 million (bizjournals.com) [edit]
  2. SEC (sec.gov) [edit]
  3. SEC (sec.gov) [edit]
Edit This Page
Last Edited 2/17/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy